Essential Hypertension Clinical Trials

14 recruiting

Essential Hypertension Trials at a Glance

15 actively recruiting trials for essential hypertension are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Seoul, Shenzhen, and Chengdu. Lead sponsors running essential hypertension studies include Addpharma Inc., Bichedam Co., Ltd., and AJU Pharm Co., Ltd..

Browse essential hypertension trials by phase

Treatments under study

About Essential Hypertension Clinical Trials

Looking for clinical trials for Essential Hypertension? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Essential Hypertension trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Essential Hypertension clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Phase 1

Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension

Healthy Volunteers Essential Hypertension
Kyowa Kirin Co., Ltd.160 enrolled3 locationsNCT06823947
Recruiting
Phase 3

Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A

Essential Hypertension
Chong Kun Dang Pharmaceutical324 enrolled1 locationNCT06643819
Recruiting
Phase 1

Safety and Pharmacokinetics Study of BCD101 in Healthy Volunteers

Essential Hypertension
Bichedam Co., Ltd.56 enrolled1 locationNCT07282145
Recruiting

Childhood-Onset Essential Hypertension Natural History Study

HypertensionEssential Hypertension
National Human Genome Research Institute (NHGRI)2,300 enrolled1 locationNCT06778239
Recruiting
Not Applicable

To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary Hypertension

Essential Hypertension
Lepu Medical Technology (Beijing) Co., Ltd.213 enrolled18 locationsNCT07051811
Recruiting
Not Applicable

Safety and Efficacy of Modulated Ultrasound Renal Denervation for HTN(FIM)

Essential Hypertension
Shenzhen Pulsecare Medical Technology Co., Ltd.6 enrolled1 locationNCT06877234
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B

Essential Hypertension
Addpharma Inc.251 enrolled1 locationNCT06441630
Recruiting
Not Applicable

Effects of Remote Ischemic Conditioning on Blood Pressure in Older Patients With Hypertension

Essential Hypertension
Yi Yang158 enrolled1 locationNCT05845905
Recruiting
Not Applicable

Investigation of the Effect of Mobile Software Use in Blood Pressure Management of Hypertensive Individuals on Quality of Life and Disease Self-Efficacy

Hypertension, Essential Hypertension
Inonu University614 enrolled1 locationNCT06321159
Recruiting
Not Applicable

Superselective Adrenal Arterial Embolization for Refractory Hypertension: A Proof-of-Concept Study

Essential Hypertension
Second Affiliated Hospital of Nanchang University20 enrolled1 locationNCT06568640
Recruiting
Phase 4

Study of Bisoprolol (Nerkardou - Nerhadou International) 5 and 10 mg Oral Dissolvable Film (ODF) Treatment in Egyptian Patients With Essential Hypertension

Essential Hypertension
Genuine Research Center, Egypt406 enrolled1 locationNCT05880056
Recruiting

A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China

Liver CancerPancreatic CancerGastric Cancer+8 more
Zhujiang Hospital12,000 enrolled50 locationsNCT05638269
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy

Essential HypertensionType 2 Diabetes Mellitus
Boryung Pharmaceutical Co., Ltd276 enrolled2 locationsNCT06220773
Recruiting
Phase 3

Efficacy and Safety of AJU-C52 in Essential Hypertension Patients

Essential Hypertension
AJU Pharm Co., Ltd.190 enrolled1 locationNCT06416865
Recruiting

Water and Electrolytes Content in HYpertension (WHYSKI) in the SKIn

HypertensionEssential HypertensionAldosterone-Producing Adenoma+5 more
University Hospital Padova35 enrolled1 locationNCT06090617